UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in XENE — Xenon Pharmaceuticals Inc.
CIK 861177
NEW YORK, NY
Position in XENE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$21,815,899
+$21,805,322 QoQ
Shares Held
375,166
+158868.6% QoQ
Ownership
0.388%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 76.40031346124115.ToString("F0")%
Shared 0.ToString("F0")%
None 23.599686538758842.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. XENE ranks #28 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in XENE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,815,899 | 375,166 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,577 | 236 | Shares | Defined | 2026-02-13 | |
| 2025-06-30 | $12,657,216 | 404,384 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,132,706 | 63,568 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $7,520,594 | 191,852 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,404,827 | 162,683 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,334,547 | 162,466 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,335,684 | 77,484 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,568,909 | 77,484 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,350,240 | 68,801 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,042,501 | 53,052 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,898,728 | 53,052 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,535,324 | 38,938 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,386,382 | 38,404 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $818,540 | 26,908 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $881,515 | 28,836 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $876,655 | 28,062 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $5,941,454 | 319,090 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,991,863 | 334,741 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,195,840 | 337,831 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $4,076,848 | 368,279 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,574,052 | 364,757 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||